← Leaderboards
David Y Hui
University Of Cincinnati
$27,378,958
Attributed
$31,293,941
Total exposure
14
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$35,334,959 · 15
By mechanism
R01$30,756,256 · 12
P01$4,578,703 · 2
U24$0 · 1
Top collaborators
- Anja Jaeschke4 shared
- Catherine A Reardon-Alulis4 shared
- Philip W Shaul4 shared
Most similar at University Of Cincinnati
Same institution · by research overlap
- Anja Jaeschke$2,870,415
- Patrick Powing Tso$17,259,310
Others in their field
Top investigators on “Plasma”
- David Heimbrook · Leidos Biomedical Research, Inc.$170,532,526
- Barton F Haynes · Duke University$119,611,088
- Paul S. Aisen · Cognition Therapeutics, Inc.$110,079,727
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$93,527,289
- Walter C. Willett · Harvard University (Sch Of Public Hlth)$85,429,770
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$78,577,996
Research focus
PlasmaBaseProteinsLipidsCholesterolAtherosclerosisGenesDietObesityLiverDiabetes MellitusCellsTissuesMediatingFunctional DisorderGenetic PolymorphismAdipose TissueLow Density Lipoprotein ReceptorResearch StudyIn VitroPublic Health RelevanceCardiovascular DiseasesDesignPrograms
Grant awards (87)
Polymorphic ApoE at the crossroad of lipid metabolism and inflammation in atherosclerosis$614,941
R01 · FY2025 · HL · contact PI
Polymorphic ApoE at the crossroad of lipid metabolism and inflammation in atherosclerosis$553,447
R01 · FY2024 · HL · contact PI
Polymorphic ApoE at the crossroad of lipid metabolism and inflammation in atherosclerosis$614,941
R01 · FY2023 · HL · contact PI
ApoE receptor-2 in vascular disease progression and regression$702,327
R01 · FY2022 · HL · contact PI
Polymorphic ApoE at the crossroad of lipid metabolism and inflammation in atherosclerosis$614,941
R01 · FY2022 · HL · contact PI
ApoE receptor-2 in vascular disease progression and regression$73,510
R01 · FY2022 · HL · contact PI
ApoE receptor-2 in vascular disease progression and regression$775,946
R01 · FY2021 · HL · contact PI
ApoE receptor-2 in vascular disease progression and regression$702,327
R01 · FY2020 · HL · contact PI
Intestinal LPC/LPA modulation of gut microbiota and metabolic disease$361,125
R01 · FY2020 · DK · contact PI
ApoE receptor-2 in vascular disease progression and regression$47,427
R01 · FY2020 · HL · contact PI
ApoE receptor-2 in vascular disease progression and regression$701,789
R01 · FY2019 · HL · contact PI
Cell Type Specific Roles of ApoE2 in Tissue Inflammation and Atherosclerosis$654,752
R01 · FY2019 · HL · contact PI
Intestinal LPC/LPA modulation of gut microbiota and metabolic disease$361,125
R01 · FY2019 · DK · contact PI
LDL Receptor Related Protein-1 in Metabolic and Cardiovascular Disease$355,500
R01 · FY2019 · DK · contact PI
Cell Type Specific Roles of ApoE2 in Tissue Inflammation and Atherosclerosis$654,752
R01 · FY2018 · HL · contact PI
Intestinal LPC/LPA modulation of gut microbiota and metabolic disease$360,000
R01 · FY2018 · DK · contact PI
LDL Receptor Related Protein-1 in Metabolic and Cardiovascular Disease$355,500
R01 · FY2018 · DK · contact PI
LDL Receptor Related Protein-1 in Metabolic and Cardiovascular Disease$336,194
R01 · FY2018 · DK · contact PI
Role of Endothelial and Macrophage ApoER2 in Atherosclerosis Modulation$698,117
R01 · FY2017 · HL · contact PI
Cell Type Specific Roles of ApoE2 in Tissue Inflammation and Atherosclerosis$654,752
R01 · FY2017 · HL · contact PI
Intestinal LPC/LPA modulation of gut microbiota and metabolic disease$358,875
R01 · FY2017 · DK · contact PI
LDL Receptor Related Protein-1 in Metabolic and Cardiovascular Disease$355,500
R01 · FY2017 · DK · contact PI
Role of Endothelial and Macrophage ApoER2 in Atherosclerosis Modulation$698,117
R01 · FY2016 · HL · contact PI
Cell Type Specific Roles of ApoE2 in Tissue Inflammation and Atherosclerosis$669,252
R01 · FY2016 · HL · contact PI
LDL Receptor Related Protein-1 in Metabolic and Cardiovascular Disease$355,500
R01 · FY2016 · DK · contact PI
Intestinal LPC/LPA modulation of gut microbiota and metabolic disease$355,500
R01 · FY2016 · DK · contact PI
Role of Endothelial and Macrophage ApoER2 in Atherosclerosis Modulation$688,102
R01 · FY2015 · HL · contact PI
LDL Receptor Related Protein-1 in Metabolic and Cardiovascular Disease$355,969
R01 · FY2015 · DK · contact PI
Role of Endothelial and Macrophage ApoER2 in Atherosclerosis Modulation$713,853
R01 · FY2014 · HL · contact PI
Role of Group 1B Phospholipase A2 on Diet-induced Metabolic Diseases$329,700
R01 · FY2014 · DK · contact PI
LDL Receptor Related Protein-1 in Metabolic and Cardiovascular Disease Modulation$290,450
R01 · FY2014 · DK · contact PI
Role of Group 1B Phospholipase A2 on Diet-induced Metabolic Diseases$318,161
R01 · FY2013 · DK · contact PI
LDL Receptor Related Protein-1 in Metabolic and Cardiovascular Disease Modulation$280,284
R01 · FY2013 · DK · contact PI
Role of Group 1B Phospholipase A2 on Diet-induced Metabolic Diseases$329,700
R01 · FY2012 · DK · contact PI
LDL Receptor Related Protein-1 in Metabolic and Cardiovascular Disease Modulation$290,450
R01 · FY2012 · DK · contact PI
LDL Receptor Related Protein-1 in Metabolic and Cardiovascular Disease Modulation$392,500
R01 · FY2011 · DK · contact PI
Role of Group 1B Phospholipase A2 on Diet-induced Metabolic Diseases$392,500
R01 · FY2011 · DK · contact PI
Lipogenesis & Lipoprotein Complications of HIV Therapy$378,690
R01 · FY2010 · HL · contact PI
Phospholipase A2 in Insulin Resistance and Obesity$339,902
R01 · FY2010 · DK · contact PI
Physiological Role of NPC1L1 in Lipid Transport and Metabolism$310,270
R01 · FY2010 · DK · contact PI
Role of Lipoprotein Receptors in Diet-induced Obesity and Diabetes$264,865
R01 · FY2010 · DK · contact PI
Phospholipase A2 in Insulin Resistance and Obesity$99,877
R01 · FY2010 · DK · contact PI
Lipogenesis & Lipoprotein Complications of HIV Therapy$378,690
R01 · FY2009 · HL · contact PI
Role of Lipolytic Enzymes in Intestinal Lipid Transport$328,060
R01 · FY2009 · DK · contact PI
Physiological Role of NPC1L1 in Lipid Transport and Metabolism$313,404
R01 · FY2009 · DK · contact PI
Phospholipase A2 in Insulin Resistance and Obesity$284,832
R01 · FY2009 · DK · contact PI
Role of Lipoprotein Receptors in Diet-induced Obesity and Diabetes$267,540
R01 · FY2009 · DK · contact PI
Phospholipase A2 in Insulin Resistance and Obesity$45,359
R01 · FY2009 · DK · contact PI
Lipogenesis & Lipoprotein Complications of HIV Therapy$378,690
R01 · FY2008 · HL · contact PI
Role of Lipolytic Enzymes in Intestinal Lipid Transport$328,060
R01 · FY2008 · DK · contact PI
Physiological Role of NPC1L1 in Lipid Transport and Metabolism$313,404
R01 · FY2008 · DK · contact PI
Phospholipase A2 in Insulin Resistance and Obesity$284,832
R01 · FY2008 · DK · contact PI
Role of Lipoprotein Receptors in Diet-induced Obesity and Diabetes$267,540
R01 · FY2008 · DK · contact PI
Lipogenesis & Lipoprotein Complications of HIV Therapy$378,690
R01 · FY2007 · HL · contact PI
Role of Lipolytic Enzymes in Intestinal Lipid Transport$334,756
R01 · FY2007 · DK · contact PI
Physiological Role of NPC1L1 in Lipid Transport and Metabolism$319,800
R01 · FY2007 · DK · contact PI
Phospholipase A2 in Insulin Resistance and Obesity$290,645
R01 · FY2007 · DK · contact PI
Role of Lipoprotein Receptors in Diet-induced Obesity and Diabetes$273,000
R01 · FY2007 · DK · contact PI
Lipogenesis & Lipoprotein Complications of HIV Therapy$390,000
R01 · FY2006 · HL · contact PI
Apolipoprotein E: Impact on Vascular Cell Functions$381,790
R01 · FY2006 · HL · contact PI
Role of Lipolytic Enzymes in Intestinal Lipid Transport$344,753
R01 · FY2006 · DK · contact PI
Phospholipase A2 in Insulin Resistance and Obesity$299,325
R01 · FY2006 · DK · contact PI
Apolipoprotein E: Impact on Vascular Cell Functions$381,122
R01 · FY2005 · HL
Vascular Lipolysis: A Determinant of Atherosclerosis$382,500
R01 · FY2004 · HL
Apolipoprotein E: Impact on Vascular Cell Functions$371,114
R01 · FY2004 · HL
Role of Lipolytic Enzymes in Intestinal Lipid Transport$353,050
R01 · FY2004 · DK
LIPOGENESIS &LIPOPROTEIN COMPLICATIONS OF HIV THERAPY$344,250
R01 · FY2004 · HL
MOLECULAR MECHANISMS OF CHOLESTEROL ABSORPTION$1,052,832
P01 · FY2003 · DK
Vascular Lipolysis: A Determinant of Atherosclerosis$382,500
R01 · FY2003 · HL
Apolipoprotein E: Impact on Vascular Cell Functions$360,303
R01 · FY2003 · HL
LIPOGENESIS &LIPOPROTEIN COMPLICATIONS OF HIV THERAPY$344,250
R01 · FY2003 · HL
MOLECULAR MECHANISMS OF CHOLESTEROL ABSORPTION$1,023,964
P01 · FY2002 · DK
Vascular Lipolysis: A Determinant of Atherosclerosis$382,500
R01 · FY2002 · HL
APOLIPOPROTEIN E--IMPACT ON VASCULAR CELL FUNCTIONS$367,673
R01 · FY2002 · HL
LIPOGENESIS &LIPOPROTEIN COMPLICATIONS OF HIV THERAPY$344,250
R01 · FY2002 · HL
INTERACTIVE EFFECTS OF BILE SALT AND LIPOLYTIC ENZYMES IN CHOLESTEROL ABSORPTION$186,685
P01 · FY2002 · DK
CORE--CARDIOVASCULAR AND RENAL FUNCTIONS FACILITY$0
U24 · FY2002 · DK
MOLECULAR MECHANISMS OF CHOLESTEROL ABSORPTION$995,790
P01 · FY2001 · DK
Vascular Lipolysis: A Determinant of Atherosclerosis$382,500
R01 · FY2001 · HL
APOLIPOPROTEIN E--IMPACT ON VASCULAR CELL FUNCTIONS$358,556
R01 · FY2001 · HL
LIPOGENESIS &LIPOPROTEIN COMPLICATIONS OF HIV THERAPY$344,250
R01 · FY2001 · HL
INTERACTIVE EFFECTS OF BILE SALT AND LIPOLYTIC ENZYMES IN CHOLESTEROL ABSORPTION$186,685
P01 · FY2001 · DK
CORE--CARDIOVASCULAR AND RENAL FUNCTIONS FACILITY$0
U24 · FY2001 · DK
MOLECULAR MECHANISMS OF CHOLESTEROL ABSORPTION$968,432
P01 · FY2000 · DK
APOLIPOPROTEIN E--IMPACT ON VASCULAR CELL FUNCTIONS$348,588
R01 · FY2000 · HL
LIPOGENESIS &LIPOPROTEIN COMPLICATIONS OF HIV THERAPY$344,250
R01 · FY2000 · HL
INTERACTIVE EFFECTS OF BILE SALT AND LIPOLYTIC ENZYMES IN CHOLESTEROL ABSORPTION$164,315
P01 · FY2000 · DK